4//SEC Filing
Medytox Inc. 4
Accession 0001387131-22-009717
CIK 0001570562other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:45 PM ET
Size
7.1 KB
Accession
0001387131-22-009717
Insider Transaction Report
Form 4
Evolus, Inc.EOLS
Medytox Inc.
10% Owner
Transactions
- Sale
Common Stock, $0.00001 par value per share
2022-09-08$10.39/sh−15,300$158,979→ 7,422,352 total - Sale
Common Stock, $0.00001 par value per share
2022-09-09$10.53/sh−20,700$217,911→ 7,401,652 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.34 to $10.50, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.45 to $10.70, inclusive.
Documents
Issuer
Evolus, Inc.
CIK 0001570562
Entity typeother
IncorporatedKorea, Republic of
Related Parties
1- filerCIK 0001848514
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:45 PM ET
- Size
- 7.1 KB